Drug intelligence / Profile preview

3-aminobenzamide

Development stage
Preclinical
Lead developer
Rocket Pharmaceuticals
Modality
Small Molecules
Administration
Intraperitoneal (in Animal Studies), Not Approved For Human Use
01

Overview

**3-aminobenzamide** is a small molecule inhibitor of the enzyme poly(ADP-ribose) polymerase (PARP), a key regulator of DNA repair, transcription control, and programmed cell death. By mimicking the structure of NAD+, 3-aminobenzamide competitively binds to the catalytic domain of PARP, inhibiting its activity, thereby preventing DNA repair and leading to NAD+ and ATP depletion in cells with activated PARP, which can result in cell death. This mechanism underlies its use as a tool compound in research on DNA damage response, radiosensitization, neuroprotection, and oxidative stress injury, and it has been investigated for potential anticancer and organ-protective applications[1][2][3][5][6].

Other names
m-aminobenzamidemeta-aminobenzamidebenzamide, 3-amino-3-amino benzamide3-aminobenzoic acid amide3-carboxamidoaniline3-aminobenzamindeaniline-3-carboxamideaniline3-carboxamideaniline 3-carboxamide3-aminobenzimide3-(aminocarbonyl)aniline
02

Targets

PARP3 (Poly(adp-ribose) polymerase 3)PARP2 (Poly (adp-ribose) polymerase 2)

Beyond the preview

Go deeper on 3-aminobenzamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-aminobenzamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call